Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age

In the UK an accelerated schedule for immunisation against diphtheria, tetanus, and pertussis (injections at 2, 3, and 4 months of age) was introduced in 1990 to replace the more widely spaced schedule of 3, 5, and 9 months. There is concern, however, that the new schedule may be less immunogenic an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 1992-02, Vol.339 (8792), p.507-510
Hauptverfasser: Booy, R., Taylor, S., Tudor-Williams, G., Moxon, E.R., Aitken, S.J.M., Griffiths, H., Chapel, H.M., Ashworth, L.A.E., Macfarlane, J.A., Mayon-White, R.T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 510
container_issue 8792
container_start_page 507
container_title The Lancet (British edition)
container_volume 339
creator Booy, R.
Taylor, S.
Tudor-Williams, G.
Moxon, E.R.
Aitken, S.J.M.
Griffiths, H.
Chapel, H.M.
Ashworth, L.A.E.
Macfarlane, J.A.
Mayon-White, R.T.
description In the UK an accelerated schedule for immunisation against diphtheria, tetanus, and pertussis (injections at 2, 3, and 4 months of age) was introduced in 1990 to replace the more widely spaced schedule of 3, 5, and 9 months. There is concern, however, that the new schedule may be less immunogenic and therefore less protective than the old schedule. We have measured serum concentrations of antibodies against diphtheria, pertussis, and tetanus in infants immunised according to the two regimens. Both schedules resulted in protective concentrations of antibody against tetanus and diphtheria and in satisfactory antibody responses to three pertussis antigens (filamentous haemagglutinin, pertussis toxin, fimbriae). However, immunisation by the old schedule led to significantly higher antibody concentrations against both diphtheria and tetanus than did immunisation by the new schedule (p < 0·01). In infants immunised with the new schedule, postimmunisation antibody concentrations against tetanus toxoid and against two pertussis antigens (pertussis toxin and fimbriae) were significantly lower in infants in whom pre-immunisation (maternally derived) antibody concentrations were high (p < 0·02). The findings suggest that with an accelerated immunisation schedule maternal antibodies can have an inhibitory effect on the responses to immunisation against tetanus and pertussis.
doi_str_mv 10.1016/0140-6736(92)90336-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72808636</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0140673692903362</els_id><sourcerecordid>1694917</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-4099b9ca876f1a6ff9642d84b28606d472397ca543887181bb139c172197da483</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYMo7bb6DSwEKaKwo_k3yeSlIKVqoeCLgm8hk7mzm7KTWZPMQl_95GactYIPPgVyfvfk5FyEXlLyjhIq3xMqSCUVl280e6sJ57JiT9CKCiWqWqjvT9HqETlFZyndE0KEJPUJOqFcyEbJFfp5OwxTGDcQvPP5AY89duPQ-gAd7vx-m7cQvV3jDNmGKa2xDR3eQ8xTSj7hg3WusHjjDxCwzZitMV8ggYcx5G1hIKYpzdf1oug_SnnMbuA5etbbXYIXx_Mcfft48_X6c3X35dPt9Ye7ygnKcyWI1q12tsTuqZV9r6VgXSNa1kgiO6EY18rZWvCmUbShbUu5dlQxqlVnRcPP0evFdx_HHxOkbAafHOx2NsA4JaNYQxrJZQFf_QPej1MMJZuhWhMiuZrdxAK5OKYUoTf76AcbHwwlZt6Pmcs3c_lGM_N7P4aVsYuj99QO0P0dWhZS9MujbpOzuz7a4Hx6xOryG651wa4WDEphBw_RJOchOOh8BJdNN_r_5_gFZ8GogQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199006378</pqid></control><display><type>article</type><title>Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Business Source Complete</source><source>ProQuest Central</source><creator>Booy, R. ; Taylor, S. ; Tudor-Williams, G. ; Moxon, E.R. ; Aitken, S.J.M. ; Griffiths, H. ; Chapel, H.M. ; Ashworth, L.A.E. ; Macfarlane, J.A. ; Mayon-White, R.T.</creator><creatorcontrib>Booy, R. ; Taylor, S. ; Tudor-Williams, G. ; Moxon, E.R. ; Aitken, S.J.M. ; Griffiths, H. ; Chapel, H.M. ; Ashworth, L.A.E. ; Macfarlane, J.A. ; Mayon-White, R.T.</creatorcontrib><description>In the UK an accelerated schedule for immunisation against diphtheria, tetanus, and pertussis (injections at 2, 3, and 4 months of age) was introduced in 1990 to replace the more widely spaced schedule of 3, 5, and 9 months. There is concern, however, that the new schedule may be less immunogenic and therefore less protective than the old schedule. We have measured serum concentrations of antibodies against diphtheria, pertussis, and tetanus in infants immunised according to the two regimens. Both schedules resulted in protective concentrations of antibody against tetanus and diphtheria and in satisfactory antibody responses to three pertussis antigens (filamentous haemagglutinin, pertussis toxin, fimbriae). However, immunisation by the old schedule led to significantly higher antibody concentrations against both diphtheria and tetanus than did immunisation by the new schedule (p &lt; 0·01). In infants immunised with the new schedule, postimmunisation antibody concentrations against tetanus toxoid and against two pertussis antigens (pertussis toxin and fimbriae) were significantly lower in infants in whom pre-immunisation (maternally derived) antibody concentrations were high (p &lt; 0·02). The findings suggest that with an accelerated immunisation schedule maternal antibodies can have an inhibitory effect on the responses to immunisation against tetanus and pertussis.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(92)90336-2</identifier><identifier>PMID: 1346876</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Antibodies, Bacterial - biosynthesis ; Biological and medical sciences ; Bordetella pertussis - immunology ; Clostridium tetani - immunology ; Corynebacterium diphtheriae - immunology ; Diphtheria-Tetanus-Pertussis Vaccine - administration &amp; dosage ; Diphtheria-Tetanus-Pertussis Vaccine - immunology ; Disease ; Epidemiology. Vaccinations ; General aspects ; Humans ; Immunization ; Immunization Schedule ; Immunogenicity ; Infant ; Infants ; Infectious diseases ; Medical research ; Medical sciences ; Toxins ; Vaccines</subject><ispartof>The Lancet (British edition), 1992-02, Vol.339 (8792), p.507-510</ispartof><rights>1992</rights><rights>1992 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Feb 29, 1992</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-4099b9ca876f1a6ff9642d84b28606d472397ca543887181bb139c172197da483</citedby><cites>FETCH-LOGICAL-c413t-4099b9ca876f1a6ff9642d84b28606d472397ca543887181bb139c172197da483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/199006378?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5219399$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1346876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Booy, R.</creatorcontrib><creatorcontrib>Taylor, S.</creatorcontrib><creatorcontrib>Tudor-Williams, G.</creatorcontrib><creatorcontrib>Moxon, E.R.</creatorcontrib><creatorcontrib>Aitken, S.J.M.</creatorcontrib><creatorcontrib>Griffiths, H.</creatorcontrib><creatorcontrib>Chapel, H.M.</creatorcontrib><creatorcontrib>Ashworth, L.A.E.</creatorcontrib><creatorcontrib>Macfarlane, J.A.</creatorcontrib><creatorcontrib>Mayon-White, R.T.</creatorcontrib><title>Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>In the UK an accelerated schedule for immunisation against diphtheria, tetanus, and pertussis (injections at 2, 3, and 4 months of age) was introduced in 1990 to replace the more widely spaced schedule of 3, 5, and 9 months. There is concern, however, that the new schedule may be less immunogenic and therefore less protective than the old schedule. We have measured serum concentrations of antibodies against diphtheria, pertussis, and tetanus in infants immunised according to the two regimens. Both schedules resulted in protective concentrations of antibody against tetanus and diphtheria and in satisfactory antibody responses to three pertussis antigens (filamentous haemagglutinin, pertussis toxin, fimbriae). However, immunisation by the old schedule led to significantly higher antibody concentrations against both diphtheria and tetanus than did immunisation by the new schedule (p &lt; 0·01). In infants immunised with the new schedule, postimmunisation antibody concentrations against tetanus toxoid and against two pertussis antigens (pertussis toxin and fimbriae) were significantly lower in infants in whom pre-immunisation (maternally derived) antibody concentrations were high (p &lt; 0·02). The findings suggest that with an accelerated immunisation schedule maternal antibodies can have an inhibitory effect on the responses to immunisation against tetanus and pertussis.</description><subject>Antibodies, Bacterial - biosynthesis</subject><subject>Biological and medical sciences</subject><subject>Bordetella pertussis - immunology</subject><subject>Clostridium tetani - immunology</subject><subject>Corynebacterium diphtheriae - immunology</subject><subject>Diphtheria-Tetanus-Pertussis Vaccine - administration &amp; dosage</subject><subject>Diphtheria-Tetanus-Pertussis Vaccine - immunology</subject><subject>Disease</subject><subject>Epidemiology. Vaccinations</subject><subject>General aspects</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Schedule</subject><subject>Immunogenicity</subject><subject>Infant</subject><subject>Infants</subject><subject>Infectious diseases</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Toxins</subject><subject>Vaccines</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kV9rFDEUxYMo7bb6DSwEKaKwo_k3yeSlIKVqoeCLgm8hk7mzm7KTWZPMQl_95GactYIPPgVyfvfk5FyEXlLyjhIq3xMqSCUVl280e6sJ57JiT9CKCiWqWqjvT9HqETlFZyndE0KEJPUJOqFcyEbJFfp5OwxTGDcQvPP5AY89duPQ-gAd7vx-m7cQvV3jDNmGKa2xDR3eQ8xTSj7hg3WusHjjDxCwzZitMV8ggYcx5G1hIKYpzdf1oug_SnnMbuA5etbbXYIXx_Mcfft48_X6c3X35dPt9Ye7ygnKcyWI1q12tsTuqZV9r6VgXSNa1kgiO6EY18rZWvCmUbShbUu5dlQxqlVnRcPP0evFdx_HHxOkbAafHOx2NsA4JaNYQxrJZQFf_QPej1MMJZuhWhMiuZrdxAK5OKYUoTf76AcbHwwlZt6Pmcs3c_lGM_N7P4aVsYuj99QO0P0dWhZS9MujbpOzuz7a4Hx6xOryG651wa4WDEphBw_RJOchOOh8BJdNN_r_5_gFZ8GogQ</recordid><startdate>19920229</startdate><enddate>19920229</enddate><creator>Booy, R.</creator><creator>Taylor, S.</creator><creator>Tudor-Williams, G.</creator><creator>Moxon, E.R.</creator><creator>Aitken, S.J.M.</creator><creator>Griffiths, H.</creator><creator>Chapel, H.M.</creator><creator>Ashworth, L.A.E.</creator><creator>Macfarlane, J.A.</creator><creator>Mayon-White, R.T.</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19920229</creationdate><title>Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age</title><author>Booy, R. ; Taylor, S. ; Tudor-Williams, G. ; Moxon, E.R. ; Aitken, S.J.M. ; Griffiths, H. ; Chapel, H.M. ; Ashworth, L.A.E. ; Macfarlane, J.A. ; Mayon-White, R.T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-4099b9ca876f1a6ff9642d84b28606d472397ca543887181bb139c172197da483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Antibodies, Bacterial - biosynthesis</topic><topic>Biological and medical sciences</topic><topic>Bordetella pertussis - immunology</topic><topic>Clostridium tetani - immunology</topic><topic>Corynebacterium diphtheriae - immunology</topic><topic>Diphtheria-Tetanus-Pertussis Vaccine - administration &amp; dosage</topic><topic>Diphtheria-Tetanus-Pertussis Vaccine - immunology</topic><topic>Disease</topic><topic>Epidemiology. Vaccinations</topic><topic>General aspects</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Schedule</topic><topic>Immunogenicity</topic><topic>Infant</topic><topic>Infants</topic><topic>Infectious diseases</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Toxins</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Booy, R.</creatorcontrib><creatorcontrib>Taylor, S.</creatorcontrib><creatorcontrib>Tudor-Williams, G.</creatorcontrib><creatorcontrib>Moxon, E.R.</creatorcontrib><creatorcontrib>Aitken, S.J.M.</creatorcontrib><creatorcontrib>Griffiths, H.</creatorcontrib><creatorcontrib>Chapel, H.M.</creatorcontrib><creatorcontrib>Ashworth, L.A.E.</creatorcontrib><creatorcontrib>Macfarlane, J.A.</creatorcontrib><creatorcontrib>Mayon-White, R.T.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Booy, R.</au><au>Taylor, S.</au><au>Tudor-Williams, G.</au><au>Moxon, E.R.</au><au>Aitken, S.J.M.</au><au>Griffiths, H.</au><au>Chapel, H.M.</au><au>Ashworth, L.A.E.</au><au>Macfarlane, J.A.</au><au>Mayon-White, R.T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1992-02-29</date><risdate>1992</risdate><volume>339</volume><issue>8792</issue><spage>507</spage><epage>510</epage><pages>507-510</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>In the UK an accelerated schedule for immunisation against diphtheria, tetanus, and pertussis (injections at 2, 3, and 4 months of age) was introduced in 1990 to replace the more widely spaced schedule of 3, 5, and 9 months. There is concern, however, that the new schedule may be less immunogenic and therefore less protective than the old schedule. We have measured serum concentrations of antibodies against diphtheria, pertussis, and tetanus in infants immunised according to the two regimens. Both schedules resulted in protective concentrations of antibody against tetanus and diphtheria and in satisfactory antibody responses to three pertussis antigens (filamentous haemagglutinin, pertussis toxin, fimbriae). However, immunisation by the old schedule led to significantly higher antibody concentrations against both diphtheria and tetanus than did immunisation by the new schedule (p &lt; 0·01). In infants immunised with the new schedule, postimmunisation antibody concentrations against tetanus toxoid and against two pertussis antigens (pertussis toxin and fimbriae) were significantly lower in infants in whom pre-immunisation (maternally derived) antibody concentrations were high (p &lt; 0·02). The findings suggest that with an accelerated immunisation schedule maternal antibodies can have an inhibitory effect on the responses to immunisation against tetanus and pertussis.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>1346876</pmid><doi>10.1016/0140-6736(92)90336-2</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 1992-02, Vol.339 (8792), p.507-510
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_72808636
source MEDLINE; Elsevier ScienceDirect Journals; Business Source Complete; ProQuest Central
subjects Antibodies, Bacterial - biosynthesis
Biological and medical sciences
Bordetella pertussis - immunology
Clostridium tetani - immunology
Corynebacterium diphtheriae - immunology
Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage
Diphtheria-Tetanus-Pertussis Vaccine - immunology
Disease
Epidemiology. Vaccinations
General aspects
Humans
Immunization
Immunization Schedule
Immunogenicity
Infant
Infants
Infectious diseases
Medical research
Medical sciences
Toxins
Vaccines
title Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T13%3A42%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunogenicity%20of%20combined%20diphtheria,%20tetanus,%20and%20pertussis%20vaccine%20given%20at%202,%203,%20and%204%20months%20versus%203,%205,%20and%209%20months%20of%20age&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Booy,%20R.&rft.date=1992-02-29&rft.volume=339&rft.issue=8792&rft.spage=507&rft.epage=510&rft.pages=507-510&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(92)90336-2&rft_dat=%3Cproquest_cross%3E1694917%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199006378&rft_id=info:pmid/1346876&rft_els_id=0140673692903362&rfr_iscdi=true